本页面由Tiger Trade Technology Pte. Ltd.提供服务

Xeris制药

6.12
-0.0800-1.29%
盘后6.11-0.0078-0.13%18:31 EDT
成交量:143.55万
成交额:882.15万
市值:10.55亿
市盈率:1,908.33
高:6.27
开:6.21
低:6.10
收:6.20
52周最高:10.08
52周最低:3.95
股本:1.72亿
流通股本:1.59亿
量比:1.21
换手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):0.0032
每股收益(LYR):0.0032
净资产收益率:-617.16%
总资产收益率:4.40%
市净率:77.09
市盈率(LYR):1,908.33

数据加载中...

2020/04/24

重要事件披露

Current report, items 1.01, 2.03, 5.03, and 9.01
2020/04/10

重要事件披露

Current report, items 5.02 and 9.01
2020/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/21

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

重要事件披露

Current report, items 2.02 and 8.01
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/10/01

重要事件披露

Current report, items 5.02 and 9.01
2019/09/10

重要事件披露

Current report, items 1.01, 2.03, 8.01, and 9.01